Advertisement

Kawasaki Disease, Oxygen Radicals and High Dose Gammaglobulin Therapy

  • Tadatoshi Kuratsuji
  • Noriaki Shinomiya
  • Noboru Kobayashi
  • Kunihisa Takagi
  • Shunichi Shimizu
  • Tadashi Ojima
  • Eisuke Takahashi
  • Hideji Hanabusa
Part of the Basic Life Sciences book series (BLSC, volume 49)

Abstract

Kawasaki disease is an acute febrile disease with severe inflammatory reactions. The disease, which occures predominantly in infants and young children, was first described in 1967 in Japan and subsequently reported worldwide. Despite its relatively frequent occurrence and more than a decade of research, the etiology of Kawasaki disease is currently unknown.1

Keywords

Kawasaki Disease Kawasaki Disease Patient Lymph Node Syndrome Severe Inflammatory Reaction Solid Column 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D.M. Bell, Kawasaki syndrome: Still a mystery after 20 years, JAMA 254:801 (1985).PubMedCrossRefGoogle Scholar
  2. 2.
    T. Kawasaki, The new manual for diagnosis of Kawasaki disease, Shounika 26:985 (1985).Google Scholar
  3. 3.
    H. Fujiwara, C. Kawai, and Y. Hamashima, Clinicopathologic study of the conduction systems in 10 patients with Kawasaki disease, Am.Heart J. 96:744 (1978).PubMedCrossRefGoogle Scholar
  4. 4.
    Y. Niwa and K. Somiya, Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thrombosis, J. Pediatr. 104:56 (1984).PubMedCrossRefGoogle Scholar
  5. 5.
    K. Furusho, T. Kamiya, H. Nakano, N. Kiyosawa, K. Shinomiya, T. Hayashidera, T. Tamura, O. Hirose, Y. Manabe, Y. Yokoyama, M. Kawarano, K. Baba, and C. Mori, High-dose intravenous gammaglobulin for Kawasaki disease, Lancet 2:1055 (1984).PubMedCrossRefGoogle Scholar
  6. 6.
    A. Nishida, K. Sugioka, M. Nakano, and K. Yagi, Use of 2-methyl-6-phenyl-3,7-dihydroimidazole[l,2 – 3-pyrazin-3-on for assay of superoxide anion in phagocytizing granulocytes, J.Clin.Biochem.Nutr. 1:5 (1986).CrossRefGoogle Scholar
  7. 7.
    D.A. Bass, J.W. Parce, L.R. Dechatelet, P. Szejda, M.C. Seeds, and M. Thomas, Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation, J.Immunol. 130:1910 (1983).PubMedGoogle Scholar
  8. 8.
    K. Yagi, A simple fluorometric assay for lipoperoxide in blood plasma, Biochem.Med. 15:212 (1976).PubMedCrossRefGoogle Scholar
  9. 9.
    D.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall, Protein measurement with the Folin phenol reagent, J.Biol.Chem. 193:265 (1951).PubMedGoogle Scholar
  10. 10.
    K. Asayama and I.M. Burr, Joint purification of mangano and cuprozinc superoxide dismutases froma single source, Analyt.Biochem. 136:336 (1984).PubMedCrossRefGoogle Scholar
  11. 11.
    K.A. Smith, The functional relationship of the interleukins, J. Exp.Med. 151:1551 (1980).PubMedCrossRefGoogle Scholar
  12. 12.
    N. Shinomiya, T. Takeda, T. Kuratsuji, K. Takagi, T. Kosaka, O. Tatsuzawa, T. Tsurumizu, T. Hashimoto, and N. Kobayashi, Variant Streptococcus sanguis as an etiological agent of Kawasaki disease, “Kawasaki Disease”, 571, (S.T. Shulman ed.), Alan R. Liss, Inc, New York (1987).Google Scholar
  13. 13.
    S.T. Shulman and A.H. Rowley, Does Kawasaki disease have a retroviral aetiology? Lancet 2:545 (1986).PubMedCrossRefGoogle Scholar
  14. 14.
    J.C. Burns, R.S. Geha, E.E. Schneeberger, J.W. Newburger, F.S. Rosen. L.S. Glezen, A.S. Huang, J. Natale, and D.Y.M. Leung, Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease, Nature 323:814 (1986).PubMedCrossRefGoogle Scholar
  15. 15.
    H. Kato, T. Fujimoto, and O. Inoue, Variant strain of Propionibacterium acnes: A clue to the aetiology of Kawasaki disease, Lancet 2:1383 (1983).PubMedCrossRefGoogle Scholar
  16. 16.
    K. Somiya, S. Fukami, Y. Niwa, Y. Mizuno, and Y. Shimoda, Treatment with liposomal superoxide dismutase of patients with Kawasaki disease, Enshou 5:141 (1985).CrossRefGoogle Scholar
  17. 17.
    D.Y.M. Leung, T. Collins, L.A. Lapierre, R.S. Geha, and J.S. Pober, Immunogloblin M antibodies present in the acute phase of Kawasaki syndrime lyse cultured vascular endothelial cells stimulated by gamma interferon, J.Clin.Invest. 77:1428 (1986).PubMedCrossRefGoogle Scholar
  18. 18.
    S.J.C. Warner, K.R. Auger, and P. Libby, Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells, J. Exp. Med. 165:1316 (1987).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Tadatoshi Kuratsuji
    • 1
  • Noriaki Shinomiya
    • 1
  • Noboru Kobayashi
    • 1
  • Kunihisa Takagi
    • 2
  • Shunichi Shimizu
    • 2
  • Tadashi Ojima
    • 2
  • Eisuke Takahashi
    • 2
  • Hideji Hanabusa
    • 2
  1. 1.Division of Phagocytosis Research and Multidisciplinary LaboratoriesNational Children’s Medical Research CenterSetagayaku, Tokyo 154Japan
  2. 2.Department of PediatricsKeio University school of MedicineShinjukuku, Tokyo 160Japan

Personalised recommendations